|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 577.58 USD | -0.17% |
|
+2.10% | +18.54% |
| 04-14 | United Therapeutics Insider Sold Shares Worth $5,748,802, According to a Recent SEC Filing | MT |
| 04-13 | United Therapeutics Insider Sold Shares Worth $5,408,194, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 25.36B | |||||
| 825B | |||||
| 578B | |||||
| 372B | |||||
| 326B | - | ||||
| 314B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition